Cargando…
Risk assessment in COVID-19 patients: A multiclass classification approach
Understanding SARS-CoV-2 infection that causes COVID-19 disease among the population was fundamental to determine the risk factors associated with severe cases or even death. Amidst the study of the pandemic, Artificial Intelligence (AI) and Machine Learning (ML) have been successfully applied in ma...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295315/ https://www.ncbi.nlm.nih.gov/pubmed/35873009 http://dx.doi.org/10.1016/j.imu.2022.101023 |
_version_ | 1784750034752897024 |
---|---|
author | Bárcenas, Roberto Fuentes-García, Ruth |
author_facet | Bárcenas, Roberto Fuentes-García, Ruth |
author_sort | Bárcenas, Roberto |
collection | PubMed |
description | Understanding SARS-CoV-2 infection that causes COVID-19 disease among the population was fundamental to determine the risk factors associated with severe cases or even death. Amidst the study of the pandemic, Artificial Intelligence (AI) and Machine Learning (ML) have been successfully applied in many areas such as biomedicine. Using a dataset from the Mexican Ministry of Health, we performed a multiclass classification scheme for the detection of risks in COVID-19 patients and implemented three Machine Learning algorithms achieving the following accuracy measures: Random Forest (89.86%), GBM (89.37%) XGBoost (89.97%). The key findings are the identification of relevant components associated with different severities of COVID-19 disease. Among these factors, we found sex, age, days elapsed from the beginning of symptoms, symptoms such as dyspnea and polypnea; and other comorbidities such as diabetes and hypertension. This setting allows us to establish predicting algorithms to model the risk that an individual or a specific group of people face after contracting COVID-19 and the factors associated with developing complications or receiving appropriate treatment. |
format | Online Article Text |
id | pubmed-9295315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author(s). Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92953152022-07-19 Risk assessment in COVID-19 patients: A multiclass classification approach Bárcenas, Roberto Fuentes-García, Ruth Inform Med Unlocked Article Understanding SARS-CoV-2 infection that causes COVID-19 disease among the population was fundamental to determine the risk factors associated with severe cases or even death. Amidst the study of the pandemic, Artificial Intelligence (AI) and Machine Learning (ML) have been successfully applied in many areas such as biomedicine. Using a dataset from the Mexican Ministry of Health, we performed a multiclass classification scheme for the detection of risks in COVID-19 patients and implemented three Machine Learning algorithms achieving the following accuracy measures: Random Forest (89.86%), GBM (89.37%) XGBoost (89.97%). The key findings are the identification of relevant components associated with different severities of COVID-19 disease. Among these factors, we found sex, age, days elapsed from the beginning of symptoms, symptoms such as dyspnea and polypnea; and other comorbidities such as diabetes and hypertension. This setting allows us to establish predicting algorithms to model the risk that an individual or a specific group of people face after contracting COVID-19 and the factors associated with developing complications or receiving appropriate treatment. The Author(s). Published by Elsevier Ltd. 2022 2022-07-19 /pmc/articles/PMC9295315/ /pubmed/35873009 http://dx.doi.org/10.1016/j.imu.2022.101023 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Bárcenas, Roberto Fuentes-García, Ruth Risk assessment in COVID-19 patients: A multiclass classification approach |
title | Risk assessment in COVID-19 patients: A multiclass classification approach |
title_full | Risk assessment in COVID-19 patients: A multiclass classification approach |
title_fullStr | Risk assessment in COVID-19 patients: A multiclass classification approach |
title_full_unstemmed | Risk assessment in COVID-19 patients: A multiclass classification approach |
title_short | Risk assessment in COVID-19 patients: A multiclass classification approach |
title_sort | risk assessment in covid-19 patients: a multiclass classification approach |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295315/ https://www.ncbi.nlm.nih.gov/pubmed/35873009 http://dx.doi.org/10.1016/j.imu.2022.101023 |
work_keys_str_mv | AT barcenasroberto riskassessmentincovid19patientsamulticlassclassificationapproach AT fuentesgarciaruth riskassessmentincovid19patientsamulticlassclassificationapproach |